ArticleJACC. Case reports2026
Step-by-Step Femoral-Femoral Percutaneous Mechanical Aspiration Debulking of Anterior Tricuspid Valve Vegetation.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo outline a reproducible femoral-femoral venovenous AngioVac approach for debulking a large anterior tricuspid valve vegetation in a nonsurgical patient with persistent methicillin-sensitive Staphylococcus aureus bacteremia. KEY STEPS: 1) Confirm target and orientation with intraprocedural transesophageal echocardiography. 2) Obtain bilateral femoral venous access (large-bore aspiration/drainage and separate venous return). 3) Prime and completely de-air the circuit before activation. 4) Deploy the curved aspiration cannula in the right atrium and align coaxially to the vegetation using transesophageal echocardiography and fluoroscopy. 5) Start low flow and titrate (≈2.5-3.0 L/min) with short, controlled aspiration passes until substantial debulking. POTENTIAL PITFALLS: Possible complications include air entrainment, suction before full cannula deployment, poor coaxial alignment, large-bore access bleeding, arrhythmia, hemolysis, and incomplete source control. TAKE-HOME MESSAGE: Femoral-femoral venovenous access can optimize alignment to tricuspid valve anterior leaflet vegetations and facilitate debulking when surgery is not feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.